Clinical Trial Update: A Study to Evaluate the Pharmacokinetics, Safety, and Effectiveness of Certolizumab Pegol in Children With Moderate to Severe Chronic Plaque Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating pharmacokinetics, safety, and effectiveness of certolizumab pegol in children with chronic plaque psoriasis is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• Certolizumab pegol (certolizumab pegol)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Moderate Chronic Plaque Psoriasis, Severe Chronic Plaque Psoriasis | Phase 3 | Status: COMPLETED